Market Research

Equifax: K-Shaped Economy Gap Pauses for First Time in 3 Years

Atlanta – September 28, 2026 -- The three-year widening of America's K-shaped economy paused in the second quarter of 2026, according to new data from Equifax, as top-tier consumers gained ground while the most financially strained households pulled back sharply.

Thrivers gain 3.2% while Strivers contract 4.2%, the sharpest drop since Q4 2023

The Equifax Market Pulse Index recorded a 3.2% quarterly increase among Thrivers (Index above 80), a 0.9% rise in the Middle segment (Index 50-79), which represents nearly 70% of the U.S. population, and a 4.2% contraction among Strivers (Index of 49 and below). "For the last three years, we have watched the gap between the top and the bottom of the 'K' widen, while the middle class shrank. In the second quarter of 2026, that pattern paused," said Emmaline Aliff, Advisory Leader at Equifax.

Hydrogen Truck & Bus Market to Nearly Triple to $8.95B by 2035

Delray Beach – September 28, 2026 -- The global hydrogen bus and truck market is projected to grow from $3.83 billion in 2026 to $8.95 billion by 2035, a 9.9% compound annual growth rate, according to MarketsandMarkets. Demand is concentrated in long-haul freight, high-utilization transit fleets and mining operations where battery-electric charging downtime remains commercially impractical.

India commits to 1,000 hydrogen commercial vehicles by 2030

India's National Green Hydrogen Mission is shifting from pilot programs to fleet-scale deployment, targeting more than 1,000 hydrogen trucks and buses in commercial use by 2030. The government plans refueling stations at roughly 200-kilometer intervals and is evaluating decentralized hydrogen production to improve fuel economics for medium and heavy commercial vehicles.

N95 Mask Market to Triple to $11.08B by 2034 on Safety Rules

Pune – – September 26, 2026 -- The global N95 mask market is projected to grow from $3.27 billion in 2025 to $11.08 billion by 2034, a 14.52% compound annual growth rate, according to Maximize Market Research.

North America dominates as major respirator makers expand capacity

North America held the largest regional share in 2025, driven by hospital demand, workplace safety mandates, and infection-control requirements. Manufacturers including 3M, Honeywell, Moldex-Metric, Cardinal Health, and Medline Industries maintain significant production presence in the region, supporting its lead position through continued investment in respiratory-protection capacity.

Clinical Trials Market to Hit $99.4B by 2034 on AI, Decentralized Trial Growth

Pune – September 26, 2026 -- The global clinical trials market reached USD 58.19 billion in 2025 and is forecast to grow at a 6.13% compound annual rate through 2034, reaching USD 99.4 billion, according to Maximize Market Research.

North America retains dominant share on trial infrastructure and R&D spend

North America leads global trial activity, underpinned by extensive pharmaceutical and biotechnology infrastructure, significant cancer research burden, and the presence of major contract research organizations. The United States drives the bulk of regional Phase I-IV trial volume, while Canada contributes through government investment in trial infrastructure. Europe holds a substantial share as well, with the UK, France, Germany, Italy, Spain, Sweden and Austria supporting research across oncology, cardiovascular disease, CNS conditions, diabetes, obesity and autoimmune disorders.

Dietary Supplements Market to Hit $324.88B by 2034, Says MMR

Pune, India – September 26, 2026 -- The global dietary supplements market was valued at USD 186.36 billion in 2025 and is forecast to reach USD 324.88 billion by 2034, expanding at a compound annual growth rate of 6.37% between 2026 and 2034, according to a new report from Maximize Market Research.

North America dominates supplement demand on preventive healthcare spending

North America leads the global market, driven by high consumer spending on health and wellness, strong preventive healthcare awareness, and regulatory clarity that supports major dietary supplement manufacturers. The United States remains the largest contributor within the region, with strong uptake of vitamins, minerals, herbal supplements, probiotics, and sports nutrition products.

Shadow AI Governance Market to Hit $8.64B by 2032, Grow 35.6%

Delray Beach, Fla. – September 26, 2026 -- The Shadow AI Risk & Governance Market is set to expand from USD 1.39 billion in 2026 to USD 8.64 billion by 2032, a compound annual growth rate of 35.6%, according to MarketsandMarkets. The 2025 baseline stood at USD 1.02 billion, underscoring rapid acceleration as enterprises confront AI tools deployed outside centrally managed IT environments.

Unauthorized AI usage forces enterprises toward auditable governance systems

Corporate compliance teams are shifting from written AI policies to platforms that generate traceable evidence of risk assessments, approvals, and monitoring outcomes. This demand is pushing vendors to automate evidence collection and maintain audit trails across AI applications, rather than relying on manual documentation.

Liquid Handling System Market to Hit $7.79B by 2031, MarketsandMarkets Says

Delray Beach, Fla. – September 26, 2026 -- The global liquid handling system market will grow from $5.26 billion in 2026 to $7.79 billion by 2031, expanding at a compound annual growth rate of 8.2%, according to a new report from MarketsandMarkets.

Automated systems and pipettes lead segment growth

Automated systems held the largest share of the market in 2025 and are projected to post the highest CAGR of 9.0% through 2031, as pharmaceutical and biotechnology laboratories shift from manual liquid transfer to robotic platforms for pipetting, dispensing, dilution and microplate handling. Within product categories, pipettes accounted for the largest 2025 share and are forecast to grow fastest at 9.5% CAGR, driven by adoption of electronic and multi-channel pipetting systems that integrate with laboratory information management systems (LIMS) and support nanoliter-scale dispensing for genomics and cell and gene therapy workflows.

Position Sensor Market to Hit $23.4B by 2032, Fueled by EVs

Delray Beach, Fla. – September 25, 2026 -- The global position sensor market is projected to grow from $14.53 billion in 2026 to $23.40 billion by 2032, expanding at a compound annual growth rate of 8.3%, according to MarketsandMarkets.

Digital signal output segment set to post fastest growth as automakers demand real-time control

Within signal output categories, the digital segment is expected to register the highest CAGR through 2032, at roughly 8.9%. Digital position sensors transmit processed data directly to electronic control units, PLCs, and microcontrollers, simplifying integration for automotive and industrial automation systems. Growing adoption of digital interfaces such as SENT, PWM, SPI, I2C, and SSI is expanding functionality across electric vehicles, robotics, and smart factory equipment.

Aseptic Packaging Market to Reach $123.76B by 2031, MarketsandMarkets Says

Delray Beach, Fla. – September 25, 2026 -- The global aseptic packaging market will expand from USD 87.87 billion in 2026 to USD 123.76 billion by 2031, a 7.09% compound annual growth rate, according to MarketsandMarkets.

Vials, ampoules and prefillable syringes post the fastest growth at 8.48% CAGR

The pharmaceuticals application segment is set to register the market's highest growth rate as biological drugs, vaccines, monoclonal antibodies and biosimilars require sterile filling that standard terminal heat sterilization cannot achieve. Prefillable syringes and single-dose sterile containers are gaining clinical adoption to reduce medication errors and drug wastage, prompting pharmaceutical manufacturers to deploy mechanized aseptic filling lines under stricter regulatory oversight.

Autoimmune Treatment Market to Nearly Double to $321.95B by 2034

Pune – September 25, 2026 -- The global autoimmune treatment market reached USD 176.6 billion in 2025 and is forecast to expand at a 6.9% CAGR through 2034, hitting USD 321.95 billion, according to a new analysis from Maximize Market Research.

North America dominates the market on strong pharmaceutical R&D infrastructure

North America held the largest share of the market in 2025, driven by high disease prevalence, advanced healthcare infrastructure, established specialist care and elevated healthcare spending. The United States anchors regional growth, backed by leading pharmaceutical and biotechnology firms, advanced diagnostic capacity, and rising adoption of biologics, immunosuppressants, monoclonal antibodies and targeted therapies. Canada and Mexico are contributing through improving healthcare access and disease awareness.